SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-15-003889
Filing Date
2015-04-24
Accepted
2015-04-24 13:09:35
Documents
10
Period of Report
2015-06-09
Effectiveness Date
2015-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2224436zdef14a.htm DEF 14A 966650
2 G158649.JPG g158649.jpg GRAPHIC 5474
3 G500830.JPG g500830.jpg GRAPHIC 6470
4 G951328.JPG g951328.jpg GRAPHIC 6422
5 G31788.JPG g31788.jpg GRAPHIC 20890
6 G735950.JPG g735950.jpg GRAPHIC 49189
7 G17482.JPG g17482.jpg GRAPHIC 42601
8 G139134.JPG g139134.jpg GRAPHIC 10244
9 G97202BCI001.GIF g97202bci001.gif GRAPHIC 68131
10 G97202BCI002.GIF g97202bci002.gif GRAPHIC 98775
  Complete submission text file 0001047469-15-003889.txt   1393618
Mailing Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142 617 491-9700
MOMENTA PHARMACEUTICALS INC (Filer) CIK: 0001235010 (see all company filings)

IRS No.: 043561634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50797 | Film No.: 15791019
SIC: 2836 Biological Products, (No Diagnostic Substances)